The predicted driver genes are involved in various signaling pathways such as KRAS signaling in basal-like breast cancer and thyroid carcinoma, mTORC1 signaling in lung adenocarcinoma, and TNF−alpha signaling via NF − kB and p53 pathway in thyroid carcinoma. Here, KRAS is linked to breast cancer.